Suspended by PPB Kenya · PPB

CORIPRAVAC

INACTIVATED HAEMOPHILUS PARAGALLINARUM (SEROTYPES A, B AND C)

H2013/18321/003 0.5ML/BIRD

What it does

Haemophilus is a type of bacteria that can cause infections. It is important to be aware of how this bacteria can affect your health.

Commonly used for: infections caused by Haemophilus bacteria, pneumonia, meningitis, ear infections (otitis media)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2013/18321/003
Registration date
-
Expiry date
-
Status
Suspended by PPB
Active ingredient
INACTIVATED HAEMOPHILUS PARAGALLINARUM (SEROTYPES A, B AND C)
Dosage form
0.5ML/BIRD
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Murphy Chemicals
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Am Wehrhahn 30, 40211 Düsseldorf, Germany

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:46:25 · updated 2026-08-09 02:02:46

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About haemophilus

Haemophilus is a type of bacteria that can cause infections. It is important to be aware of how this bacteria can affect your health.

What it treats

  • infections caused by Haemophilus bacteria
  • pneumonia
  • meningitis
  • ear infections (otitis media)

How it works

Haemophilus bacteria can lead to various infections in the body, affecting different systems such as the respiratory system and the nervous system.

Who it's for

This information is relevant for individuals who may be at risk of infections caused by Haemophilus, particularly children and those with weakened immune systems.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About inactivated

Inactivated vaccines help your body build protection against certain diseases without causing the disease itself.

What it treats

  • prevention of infectious diseases

How it works

Inactivated vaccines contain viruses or bacteria that have been killed or inactivated, so they cannot cause disease. They stimulate your immune system to recognize and fight off the real infection if you are exposed in the future.

Who it's for

These vaccines are generally given to people of all ages, based on specific health recommendations.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About paragallinarum

Paragallinarum is used in veterinary medicine and is not commonly applied to human treatments.

How it works

Information on how it works is not available.

Who it's for

This medication is generally for veterinary use and not for human patients.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: haemophilus

Haemophilus refers to a genus of bacteria, which includes several species notable for causing human infections, especially Haemophilus influenzae. H. influenzae is a significant pathogen that can lead to conditions such as meningitis, pneumonia, and epiglottitis, particularly in children. The bacterium is non-motile, facultatively anaerobic, and can be encapsulated or non-encapsulated. The encapsulated type b (Hib) is most commonly associated with severe disease. Vaccination has dramatically decreased the incidence of Hib disease.

Indications

  • Bacterial meningitis
  • Pneumonia
  • Epiglottitis
  • Otitis media
  • Sinusitis
  • Bronchitis

Dosage

Children: Refer to specific antibiotic guidelines for pediatric dosing based on the type and severity of the infection caused by Haemophilus species.

Adults: Refer to specific antibiotic guidelines for dosing based on the type and severity of the infection caused by Haemophilus species.

Mechanism of action

H. influenzae adheres to epithelial cells via pili and other surface structures, allowing colonization of the nasopharynx. The encapsulated strains evade phagocytosis due to their polysaccharide capsule, which inhibits opsonization and complement activation. This leads to the systemic spread of the bacteria and can result in severe infections if not effectively treated.

Pharmacodynamics

H. influenzae can produce various virulence factors, including polysaccharide capsules, endotoxins, and enzymes that contribute to its pathogenicity. The bacteria can resist the effects of certain antibiotics through mechanisms such as beta-lactamase production, which hydrolyzes beta-lactam antibiotics, rendering them ineffective. The host's immune response is often inadequate to clear the infection due to the bacterium's ability to evade immune detection.

Pharmacokinetics

The pharmacokinetics of antibiotics used to treat H. influenzae infections vary based on the specific drug. Common antibiotics include ampicillin and ceftriaxone. The absorption, distribution, metabolism, and excretion depend on the antibiotic used. For example, ampicillin is well absorbed from the gastrointestinal tract, widely distributed in body tissues and fluids, and eliminated primarily via renal excretion.

Adverse effects

  • Injection site reactions
  • Fever
  • Rash
  • Irritability
  • Anaphylaxis (rare)

Precautions

  • Caution in patients with a history of severe allergic reactions
  • Monitor for signs of anaphylaxis after administration
  • Assess for underlying immunocompromised conditions

Pregnancy

Safety during pregnancy has not been established; use only if clearly needed.

Breast-feeding

Generally considered safe, but consult a healthcare provider.

Storage

Store at 2-8 degrees Celsius. Do not freeze. Protect from light.

Formulations

  • Injectable suspension
  • Oral tablets

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: inactivated

Inactivated vaccines are a type of immunization that use pathogens that have been killed or inactivated through physical or chemical processes. Unlike live vaccines, inactivated vaccines do not replicate in the host but still stimulate an immune response. These vaccines are generally considered safe and are commonly used to prevent various infectious diseases.

Indications

  • Hepatitis A
  • Hepatitis B
  • Influenza
  • Polio
  • Rabies
  • Typhoid fever

Dosage

Children: Refer to specific product guidelines for paediatric dosing, as it varies by vaccine type and indication.

Adults: Refer to specific product guidelines for adult dosing, as it varies by vaccine type and indication.

Mechanism of action

Inactivated vaccines work by introducing a form of the pathogen that cannot cause disease into the body. This stimulates the immune system to produce antibodies and memory cells specific to the pathogen, allowing for a robust immune response upon future exposure. The immune system recognizes the inactivated pathogen as foreign, leading to the activation of T-cells and B-cells, which are crucial for long-term immunity.

Pharmacodynamics

The pharmacodynamics of inactivated vaccines involve the generation of an adaptive immune response. After vaccination, the body produces specific antibodies against the inactivated pathogen. The response typically includes both humoral immunity, characterized by antibody production, and cellular immunity, involving T-cell activation. The duration of immunity can vary, and booster doses may be required to maintain adequate protection.

Pharmacokinetics

Inactivated vaccines do not have a pharmacokinetic profile like traditional drugs since they do not enter systemic circulation in the same manner. Following administration, the vaccine components are taken up by antigen-presenting cells, which process and present the antigens to T-cells. The immune response is initiated locally at the site of injection and can be influenced by factors such as the route of administration and the presence of adjuvants that enhance the immune response.

Adverse effects

  • Injection site reactions (pain, swelling, redness)
  • Fever
  • Fatigue
  • Headache
  • Myalgia
  • Chills

Precautions

  • Assess for allergies to vaccine components
  • Monitor for allergic reactions post-administration
  • Consider underlying health conditions that may affect immune response

Pregnancy

Inactivated vaccines are generally considered safe during pregnancy, but individual risk-benefit assessment is recommended.

Breast-feeding

Inactivated vaccines can be administered during breastfeeding without concern for adverse effects in the infant.

Storage

Store in a refrigerator at 2°C to 8°C. Do not freeze.

Formulations

  • Inactivated viral vaccines
  • Inactivated bacterial vaccines

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: paragallinarum

Paragallinarum, also known as Gallibacterium anatis, is a bacterium primarily known for its role in avian diseases, particularly in poultry. It is associated with respiratory infections and other systemic diseases in birds. The bacterium can lead to economic losses in poultry farming due to reduced productivity and increased mortality. Understanding its pathogenic mechanisms is crucial for the development of effective control measures.

Indications

  • Chronic respiratory disease in poultry
  • Inflammatory processes in avian species
  • Systemic infections in birds

Dosage

Children: Refer to veterinary pharmacology resources for pediatric dosing information.

Adults: Refer to clinical guidelines and veterinary pharmacology resources for specific dosing regimens.

Mechanism of action

Paragallinarum adheres to the host's epithelial cells, evading immune responses and causing localized inflammation. The bacterium produces various virulence factors, including adhesins and toxins, which facilitate colonization and tissue damage. These components disrupt normal cellular functions, promoting infection and disease progression.

Pharmacodynamics

The pharmacodynamics of treatments targeting Paragallinarum focus on inhibiting its growth and neutralizing its pathogenic effects. Antibiotics or vaccines may be used to reduce the bacterial load and mitigate the associated inflammatory response. The effectiveness of such treatments often depends on the timing of administration and the specific strain of the bacterium.

Pharmacokinetics

The pharmacokinetics of drugs used against Paragallinarum typically involve absorption after administration, distribution throughout the body, metabolism in the liver, and excretion via urine or feces. The pharmacokinetic profile can vary based on the drug class and the route of administration, influencing the duration and intensity of the therapeutic effect.

Pregnancy

Data on the use of paragallinarum during pregnancy is limited, consult a healthcare provider for guidance.

Breast-feeding

Data on the use of paragallinarum during breastfeeding is limited, consult a healthcare provider for guidance.

Storage

Store at room temperature, protect from light and moisture, and keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.

South Africa 2 products
Botswana 1 product